lung cancer

Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field
Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field
Fierce Pharma
JNJ
innovation
R&D
lung cancer
drug development
Flag link:
In a rare delay for the fast PD-1/L1 crowd, FDA tells Roche to wait on its Tecentriq/Avastin triple for lung cancer
In a rare delay for the fast PD-1/L1 crowd, FDA tells Roche to wait on its Tecentriq/Avastin triple for lung cancer
Endpoints
Genentech
Roch
Tecentriq
Avastin
lung cancer
FDA
Flag link:
Roche's Alecensa latest beneficiary of faster China drug approvals
Roche's Alecensa latest beneficiary of faster China drug approvals
Reuters
Roche
Alecensa. China
lung cancer
Flag link:
Can Sanofi compete in lung cancer? With I-O med cemiplumab, it’s aiming for third
Can Sanofi compete in lung cancer? With I-O med cemiplumab, it’s aiming for third
Fierce Pharma
Sanofi
PD-1 inhibitors
cemiplumab
lung cancer
Flag link:
How An Old Diabetes Drug Made A Big Splash At The Biggest Cancer Confab
How An Old Diabetes Drug Made A Big Splash At The Biggest Cancer Confab
Forbes
ASCO 2018
lung cancer
type 2 diabetes
metformin
Flag link:
FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers
FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers
Endpoints
Roche
Tecentriq
FDA
Genentech
lung cancer
Flag link:
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
San Francisco Gate, CA
lung cancer
cancer
Merck
Roche
Bristol-Myers Squibb
AACR
non-small cell lung cancer
Flag link:
Qiagen launches liquid biopsy tests for lung, prostate cancer
Qiagen launches liquid biopsy tests for lung, prostate cancer
Drug Delivery Business News
Qiagen
liquid biopsy
lung cancer
prostate cancer
diagnostics
AACR
Flag link:
Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say
Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say
Biopharma Dive
Hanmi Pharm
Korea
lung cancer
Olita
AstraZeneca
Tagrisso
Flag link:
With New Data, Drug Combos, Lung Cancer Experts Scramble to Keep Pace
With New Data, Drug Combos, Lung Cancer Experts Scramble to Keep Pace
Xconomy
lung cancer
immuno-oncology
Flag link:
Visiongate Announces Next Step in Commercialization of Cancer Detection Platform
Visiongate Announces Next Step in Commercialization of Cancer Detection Platform
CP Wire
VisionGate
cancer
diagnostics
Cell-CT
LuCED Lung Test
lung cancer
Flag link:
Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib
Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib
Endpoints
Pfizer
priority review
FDA
lung cancer
dacomitinib
Flag link:
Roche's Avastin could get a boost with Tecentriq's second lung cancer win this week
Roche's Avastin could get a boost with Tecentriq's second lung cancer win this week
Fierce Pharma
Roche
Avastin
Tecentriq
lung cancer
Flag link:
Roche's Tecentriq cocktail notches another lung cancer success
Roche's Tecentriq cocktail notches another lung cancer success
Yahoo/Reuters
Roche
Tecentriq
lung cancer
clinical trials
Flag link:
Is AbbVie 'Unraveling' In Solid Tumor Market After Drug Misstep?
Is AbbVie 'Unraveling' In Solid Tumor Market After Drug Misstep?
Investors Business Daily
AbbVie
solid tumors
Rova-T
lung cancer
Flag link:
Auris Health’s Surgical Robot Gets FDA Green Light for Lung Cancer
Auris Health’s Surgical Robot Gets FDA Green Light for Lung Cancer
Xconomy
Auris Health
devices
robotic surgery
FDA
lung cancer
Monarch robots
Flag link:
Is It Game Over for AbbVie's Promising Cancer Drug?
Is It Game Over for AbbVie's Promising Cancer Drug?
Motley Fool
Rova-T
AbbVie
lung cancer
Flag link:
AbbVie says not seeking accelerated approval for lung cancer drug
AbbVie says not seeking accelerated approval for lung cancer drug
Yahoo/Reuters
AbbVie
drug approvals
accelerated approvals
lung cancer
Rova-T
Flag link:
FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
Endpoints
FDA
AstraZeneca
Imfinzi
lung cancer
Bavencio
Pfizer
Merck KGaA
Flag link:
Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial
Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial
Yahoo/Reuters
Merck KGaA
Pfizer
lung cancer
Bavencio
clinical trials
Flag link:

Pages